Nano Labs Ltd Ratios | P/E, ROE & Valuation

On the Key Ratios page for Nano Labs Ltd (NA), the latest P/E of 1.5 frames valuation, while ROE 19785.74% and ROIC 7313.12% indicates profitability and capital efficiency. Together with the current ratio of 2.09 and debt-to-equity 0.31, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

NA Historical Per Share Metrics

7 years
Metric (FY)TTM202420232022202120202019
Revenue per Share$1360.87$0.60$1.33$18.47$0.76$0.04$0.00
Net Income per Share$6824.93$-1.68$-4.29$0.58$-3.37$-0.73$-0.28
Operating Cash Flow per Share$-5456.13$-2.07$-2.27$-5.16$1.38$-0.06$0.22
Free Cash Flow per Share$-5458.47$-2.61$-4.06$-6.42$1.21$-0.08$0.19
Cash per Share$19.06$4.09$0.86$1.71$5.12$0.69$0.27
Book Value per Share$37.31$3.46$-0.28$3.09$-0.48$-0.93$-0.28
Tangible Book Value per Share$35.01$2.76$-1.09$2.17$-0.48$-0.94$-0.29
Interest Debt per Share$865.10$3.06$2.58$0.44$0.15$0.11$0.18
CAPEX per Share$2.35$0.54$1.79$1.26$0.17$0.02$0.02

NA Historical Valuation Ratios

7 years
Metric (FY)TTM202420232022202120202019
Price to Earnings (P/E)1.49-38.86-29.92135.71-227.05-1082.19-3013.33
Price to Book (P/B)0.3819.06-513.4425.69-1610.67-840.95-3013.33
Price to Sales (P/S)0.04108.3596.564.31007.1219186.320
Enterprise Value to EBITDA0.01-45.2-31.5219.93-233.83-1099.75-3058.45
EV to Sales0.04112.4597.884.231001.3819172.410
EV to Operating Cash Flow-0.01-32.76-57.44-15.13550.59-13465.943877.5
EV to Free Cash Flow-0.01-25.98-32.09-12.17626.51-10284.24334.66
Enterprise Value$1.18B$4.56B$7.67B$4.16B$39.50B$40.77B$33.24B

NA Historical Profitability Ratios

7 years
Metric (FY)TTM202420232022202120202019
Return on Equity (ROE)19785.74%-49.04%1716.04%18.93%709.38%77.71%100.00%
Return on Invested Capital (ROIC)7313.12%-22.82%-193.71%16.95%1040.64%86.30%288.95%
Return on Tangible Assets12622.20%-19.89%-83.56%9.77%-19.23%-61.41%-51.05%
Earnings Yield48205.12%-2.57%-3.34%0.74%-0.44%-0.09%-0.03%
Free Cash Flow Yield-11370.28%-3.99%-3.16%-8.09%0.16%-0.01%0.02%
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%

NA Historical Liquidity & Financial Strength

7 years
Metric (FY)TTM202420232022202120202019
Current Ratio2.091.750.521.570.960.540.63
Interest Coverage4.21-14.25-283.450-350.72-9852.140
Income Quality-0.861.170.52-8.84-0.410.08-0.78
Debt to Equity0.310.86-10.240.14-0.3-0.12-0.64
Debt to Assets21.04%32.29%43.07%6.44%0.81%9.33%32.47%
Net Debt to EBITDA0-1.65-0.42-0.311.340.80.33

NA Historical Efficiency Ratios

7 years
Metric (FY)TTM202420232022202120202019
Receivables Turnover1037.290.7945.0441.431.191.820
Payables Turnover3440.151.610.7749.2415.340.230
Inventory Turnover48800.9714.127.370.20.180
Days Sales Outstanding0.35462.178.18.81306.11200.070
Days Payables Outstanding0.11227.8833.887.4123.791613.550
Days of Inventory on Hand0.07375.9925.8549.541793.282079.410

NA Historical Market Metrics

7 years
Metric (FY)TTM202420232022202120202019
Enterprise Value to EBITDA0.01-45.2-31.5219.93-233.83-1099.75-3058.45
Market Cap$953.32M$4.40B$7.56B$4.22B$39.72B$40.80B$33.24B
Enterprise Value$1.18B$4.56B$7.67B$4.16B$39.50B$40.77B$33.24B
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does Nano Labs Ltd’s P/E ratio compare with its history?

On this page, NA's current P/E is 1.5, compared with a multi-year average around 68.6. A lower P/E versus its own history is a calculated gap versus that average—not a conclusion that the stock is cheap. Pair it with profitability and earnings quality in the table (for example ROE/ROIC) to see whether the multiple moved with earnings.

What is Nano Labs Ltd market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $953.32M. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does Nano Labs Ltd’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with Nano Labs Ltd's own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does Nano Labs Ltd compare to its competitors in key financial ratios?

The fastest way to compare Nano Labs Ltd with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see Nano Labs Ltd outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do Nano Labs Ltd's liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that Nano Labs Ltd is financially strong. Current ratio is about 2.09, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 4.21, implying a stronger ability to cover interest expenses. Debt-to-equity is about 0.31, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do Nano Labs Ltd's financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If Nano Labs Ltd is sustaining strong returns (for example ROE at 19785.74% and ROIC at 7313.12%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.